Cargando…
A roadmap to using randomization in clinical trials
BACKGROUND: Randomization is the foundation of any clinical trial involving treatment comparison. It helps mitigate selection bias, promotes similarity of treatment groups with respect to important known and unknown confounders, and contributes to the validity of statistical tests. Various restricte...
Autores principales: | Berger, Vance W., Bour, Louis Joseph, Carter, Kerstine, Chipman, Jonathan J., Everett, Colin C., Heussen, Nicole, Hewitt, Catherine, Hilgers, Ralf-Dieter, Luo, Yuqun Abigail, Renteria, Jone, Ryeznik, Yevgen, Sverdlov, Oleksandr, Uschner, Diane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366748/ https://www.ncbi.nlm.nih.gov/pubmed/34399696 http://dx.doi.org/10.1186/s12874-021-01303-z |
Ejemplares similares
-
The impact of selection bias in randomized multi-arm parallel group clinical trials
por: Uschner, Diane, et al.
Publicado: (2018) -
ERDO - a framework to select an appropriate randomization procedure for clinical trials
por: Hilgers, Ralf-Dieter, et al.
Publicado: (2017) -
Pharmacometrics meets statistics—A synergy for modern drug development
por: Ryeznik, Yevgen, et al.
Publicado: (2021) -
Confidence interval comparison: Precision of maximum likelihood estimates in LLOQ affected data
por: Bülow, Tanja, et al.
Publicado: (2023) -
Assessing the impact of selection bias on test decisions in trials with a time‐to‐event outcome
por: Rückbeil, Marcia Viviane, et al.
Publicado: (2017)